VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Fernández-Marcial, C.; Roselló, M.; Ribas Mundó, M.
Medicina Clinica 90(14): 569-572
1988
ISSN/ISBN: 0025-7753 PMID: 2840536 Document Number: 318114
Document emailed within 1 workday
Related Documents
Ardizzoni, A.; Canobbio, L.; Pronzato, P.; Repetto, L.; Serrano, J.; Benvenuto, F.; Simonassi, C.; Baracco, F.; Faravelli, B.; Nosenzo, M. 1986: Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(6): 416-419Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395
McMahon, L.J.; Herman, T.S.; Manning, M.R.; Dean, J.C. 1979: Patterns of relapse in patients with small cell carcinoma of the lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy Cancer Treatment Reports 63(3): 359-362
Adachi, K.; Ogawa, M.; Inagaki, J.; Horikoshi, N.; Inoue, K.; Ikeda, K.; Usui, N.; Nakata, H.; Tada, A.; Aiba, K. 1984: A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1617-1622
Adam, Z.; Elbl, L.; Vorlícek, J.; Hájek, R.; Tomíska, M.; Hejlová, N.; Králová, E.; Novotná, H. 1994: Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) Vnitrni Lekarstvi 40(8): 506-512
Cohen, M.H.; Broder, L.E.; Fossieck, B.E.; Bull, M.; Ihde, D.C.; Minna, J.D. 1977: Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma Cancer Treatment Reports 61(3): 485-487
Sevelda, P.; Dittrich, C.; Salzer, H.; Pateisky, N.; Spona, J. 1986: Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125 Cancer Detection and Prevention 9(5-6): 521-528
Lorigan, P.; Lee, S.M.; Betticher, D.; Woodhead, M.; Weir, D.; Hanley, S.; Hardy, C.; Thatcher, N. 1995: Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer Seminars in Oncology 22(3 Suppl 7: 32-41
Perevodchikova, N.I.; Bychkov, M.B.; Ausekar, B.V. 1983: Adriamycin in the combined chemotherapy of small-cell lung cancer Antibiotiki 28(8): 628-632
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Zwitter, M.; Cufer, T.; Wein, W. 2001: Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer Neoplasma 48(3): 200-202
Ito, Y.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Imajou, K.; Ozeki, H.; Nagamine, D.; Shinagawa, K. 1987: Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3295-3300
Smith, D.B.; Thatcher, N.; Steward, W.P.; Brear, G.; Carroll, K.B. 1986: A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology 22(4): 435-437
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
Derentowicz, P.; Radomyski, A.; Araszkiewicz, Z. 1986: Evaluation of the effects of vincristine, adriamycin and cyclophosphamide on urinary excretion of magnesium in healthy rats Pneumonologia Polska 54(8): 342-347
Fraile, R.J.; Samson, M.K.; Baker, L.H.; Talley, R.W. 1979: Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 63(11-12): 1983-1987
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Eagan, R.T.; Frytak, S.; Nichols, W.C.; Ingle, J.N.; Creagan, E.T.; Kvols, L.K. 1981: Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers Cancer Treatment Reports 65(5-6): 453-458
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958